Antzeko izenburuak: Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers
- Challenges and Opportunities for Effective Cancer Immunotherapies
- The Role of Complement in Cancer Immunotherapy
- Monoclonal Antibodies and Their Functional Fragments in Research, Diagnosis and Therapy
- Recent Advances in Antibody Therapeutics
- Cancer Immunology
- Immunotherapy in Hepatocellular Carcinoma
Gaia: monoclonal antibody
- The Role of Complement in Cancer Immunotherapy
- Fibroblast Growth Factor Receptor (FGFR) Signaling Pathway in Tumor
- Cyanobacteria and Cyanotoxins: New Advances and Future Challenges
- Celebrating 120 Years of Butantan Institute Contributions for Toxinology
- Migraine Neuroscience
- Challenges and Opportunities for Effective Cancer Immunotherapies
Gaia: NSCLC
- Heterocyclic Compounds in Medicinal Chemistry
- Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
- Advances in Cancer Multimodal Approach: Biomarkers, Mechanisms, Surgical Procedures and Oncological Therapies
- Role of Medical Imaging in Cancers
- Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development
- Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)